We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 9,475 results
  1. Review Paper: Reporting Practices for Task fMRI Studies

    What are the standards for the reporting methods and results of fMRI studies, and how have they evolved over the years? To answer this question we...

    Freya Acar, Camille Maumet, ... Beatrijs Moerkerke in Neuroinformatics
    Article 06 October 2022
  2. Best practices for the interpretation and reporting of clinical whole genome sequencing

    Whole genome sequencing (WGS) shows promise as a first-tier diagnostic test for patients with rare genetic disorders. However, standards addressing...

    Christina A. Austin-Tse, Vaidehi Jobanputra, ... Heidi L. Rehm in npj Genomic Medicine
    Article Open access 08 April 2022
  3. Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey

    Abstract

    This study aimed to investigate the current knowledge and experiences of consumers in Australia on adverse drug reaction (ADR) reporting and...

    Mohammed Gebre Dedefo, Renly Lim, ... Lisa Kalisch Ellett in European Journal of Clinical Pharmacology
    Article Open access 12 July 2024
  4. Improving the Eligibility of Task-Based fMRI Studies for Meta-Analysis: A Review and Reporting Recommendations

    Decisions made during the analysis or reporting of an fMRI study influence the eligibility of that study to be entered into a meta-analysis. In a...

    Freya Acar, Camille Maumet, ... Beatrijs Moerkerke in Neuroinformatics
    Article 04 November 2023
  5. Reporting of ADRs Across the Globe: India, USA, EU, and Non-EU

    This chapter conducts a comparative analysis of adverse drug reaction (ADR) reporting practices in four prominent global regions: India, the United...
    Priyanka Sharma, Mukesh Nandave, Anoop Kumar in Pharmacovigilance Essentials
    Chapter 2024
  6. Imprecision in vaccine adverse event reporting and a methodological analysis of reporting systems to improve pharmacovigilance and public health

    Introduction

    This study documents imprecision in Japanese reports of adverse events following immunization (AEFI). In doing so, it presents methods to...

    Yasuko Inokuma, Robert Kneller in European Journal of Clinical Pharmacology
    Article 30 May 2023
  7. A framework for the evaluation and reporting of incidental findings in clinical genomic testing

    Currently, there are no widely accepted recommendations in the genomics field guiding the return of incidental findings (IFs), defined here as...

    Carolyn M. Brown, Laura M. Amendola, ... Alison J. Coffey in European Journal of Human Genetics
    Article 02 April 2024
  8. A focused review of statistical practices for relating radiation dose-volume exposure and toxicity

    Purpose

    Relating dose-volume histogram (DVH) information to patient outcomes is critical for outcomes research in radiation oncology, but this is...

    Andrew M. McDonald, Craig S. Schneider, ... Charles S. Mayo in Radiation Oncology
    Article Open access 24 March 2023
  9. Neutralizing Antibody Validation Testing and Reporting Harmonization

    Evolving immunogenicity assay performance expectations and a lack of harmonized neutralizing antibody validation testing and reporting tools have...

    Heather Myler, João Pedras-Vasconcelos, ... Stephanie Pasas-Farmer in The AAPS Journal
    Article Open access 08 July 2023
  10. Protocols, policies and practices for antimicrobial stewardship in hospitalized patients in least-developed and low-income countries: a systematic review

    Background

    We aimed to identify interventions used to implement antimicrobial stewardship practices among hospitalized patients in least-developed...

    Grace Wezi Mzumara, Michael Mambiya, Pui-Ying Iroh Tam in Antimicrobial Resistance & Infection Control
    Article Open access 23 November 2023
  11. Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer

    Non-small cell lung cancer is a heterogeneous disease and molecular characterisation plays an important role in its clinical management....

    Umberto Malapelle, Natasha Leighl, ... Christian Rolfo in British Journal of Cancer
    Article Open access 15 May 2024
  12. Consensus Head Acceleration Measurement Practices (CHAMP): Origins, Methods, Transparency and Disclosure

    The use of head kinematic measurement devices has recently proliferated owing to technology advances that make such measurement more feasible. In...

    Kristy B. Arbogast, Jaclyn B. Caccese, ... Jeff R. Crandall in Annals of Biomedical Engineering
    Article Open access 03 August 2022
  13. Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey

    Antinuclear antibodies (ANA) are the most widely used immunological test for the diagnosis of autoimmune diseases. Despite the recommendations of...

    Laura Martinez-Martinez, Juan Irure-Ventura, ... Mª José Zaro in Immunologic Research
    Article 17 May 2023
  14. Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting

    Alzheimer’s disease (AD), the most common form of dementia, remains challenging to understand and treat despite decades of research and clinical...

    Xuemei Zeng, Yijun Chen, ... Thomas K. Karikari in Molecular Neurodegeneration
    Article Open access 15 May 2024
  15. Knowledge of Human Papillomavirus (HPV), Attitudes, and Practices Towards Anti-HPV Vaccination Among Israeli Nurses

    Human papillomavirus (HPV) is a small, non-enveloped, double-stranded DNA virus, belonging to the family of Papillomaviridae . It is a highly common...

    Rola Khamisy-Farah, Maher Endrawis, ... Nicola Luigi Bragazzi in Journal of Cancer Education
    Article 13 March 2023
  16. Analysis of laboratory reporting practices using a quality assessment of a virtual patient

    Purpose

    Existing research suggests that while some laboratories report variants of uncertain significance, unsolicited findings (UF), and/or secondary...

    Danya F. Vears, Martin Elferink, ... Koen L. van Gassen in Genetics in Medicine
    Article 30 October 2020
  17. Challenges and best practices in omics benchmarking

    Technological advances enabling massively parallel measurement of biological features — such as microarrays, high-throughput sequencing and mass...

    Thomas G. Brooks, Nicholas F. Lahens, ... Gregory R. Grant in Nature Reviews Genetics
    Article 12 January 2024
  18. Pharmacovigilance study of BCR-ABL1 tyrosine kinase inhibitors: a safety analysis of the FDA adverse event reporting system

    Background

    With the increased use of BCR-ABL1 tyrosine kinase inhibitors (TKIs) in cancer patients, adverse events (AEs) have garnered considerable...

    Dehua Zhao, **aoqing Long, Jisheng Wang in BMC Pharmacology and Toxicology
    Article Open access 23 February 2024
  19. Tri©DB: an integrated platform of knowledgebase and reporting system for cancer precision medicine

    Background

    With the development of cancer precision medicine, a huge amount of high-dimensional cancer information has rapidly accumulated regarding...

    Wei Jiang, Peng-Ying Wang, ... Yun-Juan Bao in Journal of Translational Medicine
    Article Open access 06 December 2023
  20. Knowledge, attitudes and practices towards community-acquired pneumonia and COVID-19 among general population: a cross-sectional study

    Background

    This study aimed to assess the knowledge, attitudes, and practices (KAP) of the general population to community-acquired pneumonia (CAP)...

    Er Hong, Jia Mao, ... Wei Tao in Antimicrobial Resistance & Infection Control
    Article Open access 17 January 2024
Did you find what you were looking for? Share feedback.